α受体阻滞剂治疗ⅢB型前列腺炎导致的获得性早泄的临床观察  

clinical observation of α-blocker treatment of acquired premature ejaculation caused by Ⅲ B prostatitis

作　　者：李文通[1] 吴建军[1] 虎华静[1] 庞健[1] 胡峰[1] 李昱亮[1] 

机构地区：[1]四川省成都市第六人民医院泌尿外科,四川成都610051

出　　处：《湖南中医药大学学报》2009年第10期48-50,共3页Journal of Hunan University of Chinese Medicine

摘　　要：目的评估萘哌地尔分散片在治疗ⅢB型CP导致的获得性早泄中的疗效。方法46例ⅢB型CP合并PE患者口服萘哌地尔分散片,治疗8 w,并用前列腺炎症状评分、性生活质量评分、尿动力学检查等方法评价其疗效。结果治疗前后,在前列腺炎症状评分、性生活质量评分及尿动力学参数方面均有明显改善。结论萘哌地尔分散片能明显改善ⅢB型CP导致的获得性早泄的相关症状,值得临床推广。Objective To evaluate the uaflopidil dispersible tablets in the treatment of Ⅲ B-type CP was caused by the effects of premature ejaculation.Methods 46 patients with type ⅢB combined PE in patients with CP naftopidil oral tablet, treatment, 8 w, and use prostatitis symptom scores, sexual quality of life scores, urodyuamic evaluation of its efficacy and other methods.Results before and after treatment, in the prostatitis symptom score, sexual quality of life score and urodyuamic parameters were significantly improved.Conclusion Naftopidil tablet can significantly improve Ⅲ B-type CP due to acquired premature ejaculation-related symptoms, worthy to be popularized.

关 键 词：Α受体阻断剂 前列腺炎 早泄 

分 类 号：R749.3[医药卫生—神经病学与精神病学] R277.573.3[医药卫生—临床医学]